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Introduction
The last two decades witnessed an enormous research rush to reveal the pharmacological 
actions of an annual spicy delicate and beautiful herb known by the Latin name Nigella sativa
Linnaeus variety hispidula (brachyloba) that belongs to the botanical family Ranunculaceae. It 
was first identified and described by Linnaeus in 1753[1].  The plant is an erect profusely 
branched herb that can attain heights of 40 and up to 70cm. It bears alternate leaves, terminal 
white flowers and capsule like fruits.  The latter are filled with black ovoid or obpyramidal seeds 
attaining lengths and widths ranging from 2.5 to 3.5mm and widths from 1.5 to 2mm.
respectively. The detailed taxonomy of the plant was described by Muschler [2].  The plant is 
known to all Arabian and Islamic countries and carries various colloquial names.  It is known 
generally by the names Habbat Albarakah, Alhabahat Alsawda and Alkamoun Alaswad.  In 
some countries it is known by the names Shuniz and Khodhira.  Its English name is Black 
Cumin or Black Caraway.  It should be noted that the latter two names bear no relation to the 
plants Cumin (Cuminum cyminum, Linne) and Caraway (Caram carvi, Linne) that belong to the 
botanical family Umbelliferae.
Of all the plant organs it is only the seeds which attracted most of the researchers starting 
from Egypt and the Sudan in Africa and extending to Saudi Arabia, India and Pakistan in Asia 
and most recently those in Japan, France, England, Canada and USA.
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REVIEW ARTICLE
Abstract: This review almost covers what is actually known to date about the black seed and its constituents.  It is 
clear that most of the potent and fruitful activity resides in its volatile oil and a protein component. However, the 
volatile oil suffers the drawback of the bronhoconstricting effect of thymoquinone.  However, the latter can be 
easily removed from the oil to obtain a dethymoquinoneated oil that has already been shown to possess the major 
characteristics of the whole oil.  At this moment there are a lot of experimental data that hopefully, may stimulate 
the beginning of the era of pilot clinical studies to evaluate the clinical potential of the volatile oil, some of the 
protein fractions and the dethymoquinoneated volatile oil.  It is hoped that this plea will have a rapid response. 
Key words: Blackseed, Thymoquinone, P-Cymene, 1 -pinene –hederin, Nigellane
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During the last two decades, literature is replete with the subject of pharmacological 
actions of a pure component or an extract of the seeds.  Most of the studies dealt with the 
volatile oil of the seeds and its major constituents.  These studies revealed a multi-range of
actions that covered almost all known ailments of man in the various body systems.This review 
is mainly intended to provide a comprehensive knowledge regarding our existing knowledge of 
the pharmacological and toxicological actions of this plant. It is hoped that the provided
knowledge will generate a real clinical appraisal and evaluation of the effectiveness of at least 
the volatile oil of the seeds in the treatment of some cardiovascular diseases.
1.1 The Chemical Composition of the Seeds 
Historically, the chemical investigations on the N. sativa seeds started on the year 1880 
when Greenish [3] published the first report concerning the presence of 37% oil and 4.1% ash 
(calcium salts) in the seeds.  The general chemical composition of the seeds as we know it today 
is depicted in Table 1. 
Table 1:  The general chemical composition of N. sativa seeds*
Constituent % Range (w/w)
Oil 31-35.5
Protein 16-19.9
Carbohydrates 33-34
Fibre 4.5-6.5
Ash 3.7-7
Saponins 0.013
Moisture 5-7
* References [5-10]
1.1.1. Chemical Composition of N. sativa Oil
The chemical analysis of N. sativa total oil revealed the presence of both a fixed oil and a 
volatile oil.  The major component was the fixed oil whereas the volatile oil ranged from 0.4-
0.7% of the seeds’ weight [5, 7, 9].  The fixed oil chemical composition is outlined in Table 2.
                          Table 2:  The chemical composition of N. sativa fixed oil*
Constituent % Range (w/w)
Linoleic Acid 44.7-56
Oleic Acid 20.7-24.6
Linolenic Acid 0.6-1.8
Arachidic Acid 2-3
Palmitoleic Acid 3
Eicosadienoic Acid 2-2.5
Palmitic Acid 12-14.3
Stearic Acid 2.7-3
Myristic Acid 0.16
Sterols 0.5
                                                 *References [6, 11-13]
                                                                                                                                                                                                                                                               J T U Med Sc 2006; 1(1)
3      The Black Seed…..
Generally, there were no significant variations in the chemical composition of the fixed 
oils of seeds grown in Egypt, Sudan, Ethiopia, India, Turkey and Syria.   However, Al-Jassir [7]
noted that the seeds grown in Qassim, Saudi Arabia, contained, in addition to the fatty acids 
depicted in Table 2, two more acids which were lignoceric acid about (1%) and myristoleic acid 
(0.18%) without the presence of eicosadienoic acid  (C20:2).  Lignoceric acid is not found in 
many other edible vegetable oils.
Specific chemical analyses of the volatile oil started during the years 1960-1963 by 
Mahfouz and El-Dakhakhny [13] and Canonica et al [14].  These studies were complemented by 
most recent ones which revealed various pharmacologically active constituents that included 
Thymoquinone (2-isopropyl-5-methyl-benzoquinone) that may attain up to 27.8% of the volatile 
oil (w/w) [12, 14-17], Carvacrol (2-methyl-5-(1-methyl ethyl) phenol which is also known as 2-
hydroxy-p-cymene or isothymol) (5.8-11.6% (w/w)) [18], p-cymene (isopropyl toluene) in the 
range of 15.5-31.7% (w/w) [17, 18], D-pinene  (2,6,6-trimethylbicyclo [3.1-1]-hepta-2-ene (9.3%) 
[18], 4-terpineol (or D-terpineol or D,D,4-trimethyl-3-cyclo-hexene-1-methanol or p-menth-1-en-
8-ol) 2-6.6%[17]; longifolene (or Junipene or Kuromatsuene or decahyro-4,8,8-trimethyl-9-
methylene-1,4-methanoazulene) 1-8% (w/w))[17], t-anethole (p-Propenyl anisole or 1-methoxy-
4-(1-propenyl)benzene 0.25-2.3% w/w [17] and the reduction product of thymoquinone-
thymohydroquinone[19] together with some esters about 16% [18].
1.1.2 Non-Oily Components of the Seeds 
1.1.2a Minerals
Analysis of N. sativa seeds, ash revealed the presence of 0.5-1% calcium, 0.6% 
phosphorus, 0.6% potassium and 0.1% sodium of the total seeds weight [5].
1.1.2b Saponins
The major saponin in the defatted seeds of N. sativa is the glycoside D-hederin or Helixin 
or melanthin which on acid hydrolysis releases its sugar rhamnose / arabinose and gives the 
aglycone hederagenin (or melanthigenin) or caulosapogenin [9, 20- 22].
1.1.2c Alkaloids
Three types of alkaloids were isolated from the defatted seeds of 
N. sativa.  These were identified as the indazole nigelicine [23], the isoquinoline nigellimine [24]
and its N-oxide [25] and the indazole alkaloid nigellidine [26].
1.2 Determination of N. sativa constituents
Quantitative determination of the individual fatty acids present  in the  fixed  oil  of  N.
sativa  was  achieved  using  GC/MS [5, 6, 12] whereas quantification of  the volatile  oil  
constituents  was  performed  using  thin layer chromatography[27] and high performance liquid 
chromatography[28].
2.  Pharmacological Actions of N. sativa
Since 1960 to date various researchers throughout the world reported the 
pharmacological actions of the whole seeds of N. sativa as crushed powder or as an extract 
together with those of some of its constituents such as its total, fixed or volatile oils or the 
individual constituents of the latter.  The most extensive studies concerned the volatile oil and its 
constituent thymoquinone. The results of these studies will be reviewed later.  Some of the
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studies dealt with the acute toxicity of the seeds and its components. In these studies the acute 
LD50 values of the fixed oil and volatile oil were found to be 11.9 ml/kg i.p. and 0.54 ml/kg
i.p. in mice, respectively[29]. In another study mice tolerated the methanolic and the chloroform 
extracts for up to 21 g/kg orally [30].  The LD50 of the fixed oil in rats was found to be 12 ml/kg 
i.p. (unpublished observations).  With regard to the whole powdered seeds, mice tolerated doses 
of 2g/kg orally/day for 5 days [31]. Humans also tolerated doses of 2 g of the crushed seeds per 
day for 28 days [32].
2.1 Pharmacological Actions of the Whole Crushed Seeds
Treatment of human volunteers with whole seeds’ powder at doses of 1g twice daily for 
4 weeks increased the ratio of T-lymphocytes helper cells to T-suppressor cells by 72% and 
enhanced T-killer cells function and number [32].  On the other hand, treatment of the human 
volunteers with the same dose for two weeks did not produce clear cut stable changes in the 
blood glucose, cholesterol or triglycerides levels [33].  Clinical studies in children revealed that 
administration of the powdered seeds orally at does of 40mg/kg to those infected with Ascaris
lumbricoides, Taenia saginata or Hymenolepsis nana decreased the parasites’ fecal eggs count 
by up to 93% [34].
Regarding the effects of the whole seeds in animals, significant enhancement of the 
phagocytic activity against Candida albicans was noted in mice at doses of 2g/kg/day for 5 days
[31] and significant enhancement of milk production was observed in goats at doses of 
0.1g/kg/day [35].  Treatment of rats with a suspension of the seeds at a dose level of 0.8 g/kg/day 
orally for 4 weeks protected against CCl4-induced hepatotoxicity as reflected by the significant 
decreases in the plasma levels of Alanine transaminase (ALT) and Aspartate transaminase 
(AST) enzymes together with significant decreases in the plasma level of lipid peroxides 
measured as malondialdehyde and significant increases in the erythrocytes’ content of 
glutathione peroxidase and superoxide dismutase [36].
Studies in vitro using the crushed seeds against the different stages of Schistosoma
mansoni namely the Miracidia and Cercariae revealed that exposure of the parasites to 
concentrations of 2-5 μg/ml resulted in 50-100% death of the parasites.  Furthermore, exposure 
of the adult male and female worms to the seeds’ powder in concentrations of 60-100 μg/ml 
induced 50-100% mortality [37]. At the same time, the seeds treatment decreased the activity of 
the antioxidant enzymes superoxide dismutase and glutathione peroxide and limited the energy 
production of the adult parasite via inhibition of the glycolytic enzyme hexokinase [37].
Furthermore, studies may characterize the active antischistosomal component of the seeds, a
possible candidate being the isoquinoline alkaloids mentioned earlier. 
Experiments in vivo in rats revealed that treatment of the animals with the whole seeds’ 
powder mixed with the daily feed to provide doses of 250 mg/kg/day for 7 weeks induced 
significant protection against methionine-induced hyperhomocysteinemia suggesting a potential 
role of the seeds in prophylaxis against occlusive vascular diseases [38].
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2.2 Pharmacological Actions of the Seeds’ Aqueous Extract
Aqueous extracts of N. sativa seeds were studied both in vitro and in vivo.
Administration of the aqueous extract in doses of 2 g/kg orally to rats induced significant 
protection against aspirin-induced increases in the volume of the gastric juice, the acid output 
and the gastric ulcers [39].  Studies in alloxan-diabetic rabbits revealed the ability of a 5% boiled 
aqueous extract administered at doses equivalent to 1g seed powder/kg/day orally for two 
months to significantly decrease the elevated blood glucose level and to increase the plasma 
level of tri-iodothyronine [40].  A similar treatment to the diabetic rabbits also suppressed the 
magnitude of lipids peroxidation and increased the plasma levels of reduced glutathione and 
ceruloplasmin [40].
Exposure of guinea-pigs to 5% aqueous extracts (boiled or unboiled) in the form of 
aerosols for 7 minutes protected the animals against 10% citric acid aerosols-induced cough in a 
manner equivalent to that exerted by 3% Codeine aerosols [41, 42].
Experiments in Candida-albicans-inoculated mice revealed the ability of an aqueous 
extract of the seeds at doses equivalent to 200 mg of the seeds protein/kg/day orally for 3 days to 
suppress the growth of the Candida by 5-11 folds in the kidney, liver and spleen of the animals 
[44].
Treatment of rats with an aqueous extract of the seeds resulted in significant inhibitions 
of experimentally-induced inflammations and pain but not fever [45].
Various in vitro studies were performed using the aqueous extract of the seeds or its
protein fractions. In one of these studies exposure of human lymphocytes to the 10% aqueous 
extract in concentrations up to 5 μg/ml induced marked stimulation of the release of interleukin-
3whereas exposure of the human macrophages resulted in increased release of Interleukin-1E
[45].  In subsequent experiments exposure of the human leukocytes to the protein fraction of the 
seeds in concentrations of 1-2 μg/ml enhanced production of TNF-D in Pokweed nitrogen-
activated and non-activated cells and significantly increased the production of IL-8 in the 
activated cells only [45].
In the isolated rat pancreatic islets of Langerhan, exposure of the cells to aqueous 
extracts or their basic aqueous subfractions in concentrations up to 5 mg/ml induced significant 
increases in insulin release [46]. Exposure of the isolated guinea-pig trachea to an aqueous extract 
of the seeds antagonized ACh- and histamine-induced contractions in a non-calcium antagonistic 
mechanism [47].  However, in the isolated heart, the extract produced negative inotropic and 
chronotropic actions via a seemingly calcium-channel blocking effect [48].
2.3 Pharmacological Actions of the Seeds’ Ethanolic Extract
A few experiments were performed using the alcoholic extract of the seeds both for in
vivo and in vitro studies.  These studies revealed the successful effectiveness of the alcoholic 
extract of N-sativa seeds in doses of 150 mg/kg daily for 8 days in inducing significant
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reductions of the volume of the gastric secretion, the free acid, the total acid content and the 
gastric ulcers induced by pyloric ligation in rats[49].  The extract in single doses equivalent to 40
mg powdered seeds/kg also significantly decreased the cestodal foecal egg count by 93% in 
children infected with some cestodes such as Ascaris lumbricoidis, Taenia saginata or 
Hymenolepsis nana [35]. Studies in rabbits also revealed the successful protection of the extract 
against CCl4-induced liver fibrosis and cirrhosis [50]. In vitro studies using the isolated rabbit 
jejunum revealed the spasmolytic activity of the extract via a calcium channel blocking action
[51].
2.4 Pharmacological Actions of the Methanolic Extract
In vitro exposure of oral and various other carcinomas such as Ehrlich ascites cells, 
Dalton’s Lymphoma ascites cells and sarcoma – 180 cells to the methanolic extract of N. sativa
seeds in concentration of 0.5-3μg resulted in significant cytotoxicity in the cells [52].  These 
results stimulated the researchers to investigate the influence of the extract in vivo in mice.  The 
results revealed that treatment of mice with the extract at doses of 10 mg/kg/day (i.p) for 10 days 
significantly suppressed Ehrlich ascites carcinoma cells development via inhibition of DNA 
synthesis in the cells [52].   In other experiments, the extract succeeded in protecting mice against 
cisplatin-induced decreases in haemoglobin and leukocytes counts [53].
Studies in vitro demonstrated the potent inhibitory effect of the methanolic extract in 
suppressing the growth of Bacillus subtilis, Escherichia coli, Streptococcus foecalis,
Staphylococcus aureus, Pseudomonas aeroginosa, and Candida albicans [54].  The effective in
vitro concentrations ranged from 62.5 μg – 1000 μg/ml. 
2.5 Pharmacological Actions of Petroleum Ether Extract
Administration of the dried petroleum ether extract of N. sativa seeds to rats by gavage 
orally for four weeks resulted in significant decreases in blood triglycerides, increased high 
density lipoprotein and potentiated insulin-induced activation of protein kinase enzyme [55].
Studies in vitro using the isolated rabbit jejunum and the guinea-pig trachea revealed a 
spasmolytic and a bronchodilatory actions, respectively that involved a calcium channel 
blocking mechanism [56].
2.6 Pharmacological Actions of the Hexane Extract 
Treatment of pregnant rats with the hexane extract of the seeds during the first ten days
of pregnancy in doses equivalent to 2g seeds/kg/day orally inhibited the implantation process 
[57].
2.7 Pharmacological Actions of the Ethereal Extract
Treatment of lactating rats with the ethereal extract significantly enhanced the milk 
production [58]. Studies in vitro revealed that exposure of the gram-positive bacteria 
Staphylococcus aureus, the gram –ve Pseudomonas aerugenosa and Escherichia coli and the 
yeast Candida albicans in concentrations of 250-400 μg/disc eradicated the                  
microorganisms [59].
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2.8 Pharmacological Actions of the Volatile Oil
2.8.1 Effect on the Cardiovascular System
Cardiovascular pharmacological investigations using the volatile oil of N. sativa seeds 
were touched for the first time in 1962 when Mahfouz et al [60] reported broadly that 
administration of the volatile oil in a dose of 200 μl/kg I.M decreased the arterial blood 
pressure.  However, in 1993/1994 El Tahir et al started a series of experiments to follow the
detailed cardiovascular actions of the volatile oil and to elucidate its mechanism of action in 
both rats [61] and guinea-pigs [62].  These studies revealed the ability of the oil in doses of 4-32 
μl/kg (IV) to decrease the arterial pressure and the heart rate in a dose-dependent manner.
Using various receptor blockers, ganglionic blockers, amine depletions and the technique of 
spinal pithing, the authors came to the conclusion that the cardiovascular depressant actions of 
the oil are mediated centrally in the brain via serotoninergic mechanisms that involved activation 
of 5-HT1A receptors located on the nucleus tractus solitarius and the dorsal vagal motor nucleus 
in the brain stem [61].
Besides the actions of the volatile oil on the cardiovascular system, its effects were 
studied in various other systems and tissues as follows:
2.8.2 Effect on the Respiratory System
Influenced by the folklore claim that the black seed can treat asthma, Mahfouz and his 
collaborators investigated the effect of the volatile oil in guinea pigs and dogs.  The results 
revealed that (i.m) or (i.p) injection of the volatile oil in doses of 200 μl/kg antagonized 
histamine-induced bronchoconstriction and induced bronchodilation [61, 63].  However, the oil 
was found to be ineffective in blocking histamine H1 receptors in the trachea both in vitro [63]
and in vivo [64]. To clarify the effect of the volatile oil on the respiratory system and to elucidate 
its mechanism of action, El Tahir et al [65] performed several experiments in guinea-pigs.  The 
results revealed that intravenous administration of the oil in doses of 4-32 μl/kg induced dose-
dependent increases in the respiratory rate and increased the intra-tracheal pressure pointing to a 
strong evidence of bronchoconstriction [65]. The oil did not contract the isolated trachea.  With 
the help of various receptor blockers, mast cell stabilizers and amine depletors, the authors 
concluded that the volatile oil-induced bronchoconstriction and tachypnea were due to the 
release of histamine from pulmonary non-tracheal mast cells and circulating basophils with the  
consequent activation of the H1 receptors located on the pulmonary irritant receptors and the 
pulmonary C sensory afferent nerves resulting in activation of the afferent sensory vagal nerves 
reaching the vagal nuclei in the brain stem. The final effect will be the activation of the efferent 
vagal activity to the pulmonary system [65].
2.8.3 Effect on Body Temperature
The preliminary reports regarding the influence of the volatile oil on the body 
temperature appeared in 1997 [66] followed by a detailed review with elucidation of the 
mechanism of action in 2006[67].  These studies investigated the influence of the oil in the rectal 
temperature of mice.  Administration of the oil in doses of 100-400 μl/kg (i.p) into mice induced 
dose-dependent decreases in the body temperature with a 4qC fall in 30 minutes following the 
injection of the oil and the effect diminished to non-significant levels 3 hours later [67].  Using 
various receptor blockers, the authors revealed the mechanism of action of the induced 
hypothermia as release and/or activation of central serotoninergic receptors located on the 
temperature regulating center in the anterior part of the hypothalamus [67].
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2.8.4 Effects on Experimentally-induced Gastric Ulcers
Oral treatment of rats with N. sativa volatile oil in doses of 1 ml/kg one hour before 
induction of gastric ulcers with ethanol, significantly protected the animals against the alcohol-
induced ulcers and significantly elevated the gastric glutathione content, the gastric superoxidase 
dismutase and the glutathione-S-transferase activities together with significant reductions in 
alcohol-induced lipids peroxidation in the stomach cells [68, 69].
2.8.5 Effect on Experimentally-induced Inflammation 
Intraperitoneal treatment of rats with the volatile oil in doses of 0.6-1.5 ml/kg 
significantly suppressed carrageenan-induced paw oedemas in rats and cotton-pellet-induced 
granuloma in the abdomens [70].
2.8.6 Effect on Blood Glucose Level
Administration of the volatile oil to both alloxan diabetic rabbits [71] and rats [72] induced 
significant decreases (23-43%) in the blood glucose level without affecting insulin release.  
However, treatment of streptozotocin diabetic rats with the oil at a dose of 0.2 ml/kg/day (i.p) 
one day after streptozotocin and for 30 consecutive days resulted in significant decrease  in  the  
blood  glucose  level, an increase in the blood insulin level and partial regeneration of the  
pancreatic E-cells of the islets of Langerhan[69].
2.8.7 Effect on Experimental Cancers
Treatment of hamsters with N. sativa volatile oil did not induce any dysplastic alterations 
or carcinomas in the cheek pouches of the animals [74]. Furthermore, chemical treatment of rats 
with 1, 2-dimethyl-hydrazine-induced colon cancer in the postinitiation stage but daily treatment 
with N. sativa volatile oil for 14 weeks induced significant reductions in the colonic lesions via 
suppression of the cell proliferation in the colonic mucosa [74].  The treatment did not induce any 
harmful effects in the blood or urine parameters and no pathological changes in the various vital 
body organs. Furthermore, exposure of various human cancer cell lines to the volatile oil in 
concentrations of 120-380 μg/ml induced significant death of the cells showing clear cytotoxic 
effect [75].
2.8.8 Effect on the Gall Bladder 
Intramuscular injection of the volatile oil in a dose of 0.2ml/kg into dogs increased the 
concentration of the bile salts and the flow of bile into the intestine [60].
2.8.9 Effect on the Immune System 
Treatment of typhoid-antigen-challenged rat with the volatile oil revealed an 
immunosuppressant action as evidenced by the significant decreases in the antibody titer and the 
splenocytes and neutrophils counts [75].
2.8.10 Effect on Microorganisms 
Exposure of various types of bacteria and fungi to various concentrations of the volatile 
oil revealed a broad spectrum of antibacterial and antifungal activities.  The bacterial species 
that were more susceptible included Salmonella, Shigella shigae, Bacillus cereus, Vibrio 
cholerae, Pseudomonas aerogenosa [6, 76, 77].  Furthermore, the oil was also effective against 
multi-drug resistant strains of Staphylococcus aureus [78]. The antifungal spectrum included 
Aspergillus niger, Aspergillus flavus, Candida albicans, Microsporum gypseum and Rhizoctonia 
solani [79].
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With regard to viruses, the oil significantly suppressed the growth of the 
cytomegalovirus following its intraperitoneal administration to infected mice [80].
2.8.11 Effect on Smooth Muscles
Studies using various isolated smooth muscles revealed a smooth-muscle relaxant 
activity of the oil.  This has been shown in the isolated rabbit aorta, rabbit jejunum and the 
isolated guinea-pig trachea [51]. The suggested mechanism was the blockade of calcium channels.  
Furthermore, the oil relaxed the uterine muscle of both rats and guinea-pigs and antagonized 
oxytocin-induced uterine contraction [81].
2.9 Pharmacological Actions of Some Volatile Oil Constituents 
2.9.1 Pharmacological Actions of Thymoquinone
Thymoquinone was considered as one of the major components of
N. sativa volatile oil. For this reason, the influence of this substance (whether natural or 
synthetic) was explored in most of the systems investigated for the volatile oil. These systems 
included:
2.9.1.1 Effects on the Cardiovascular System
Administration of thymoquinone (TQ) i.v. into rats in the dose-range 0.2-1.6 mg/kg 
induced dose-dependent decreases in the arterial blood pressure and heart rate [61].  It thus 
induced cardiovascular depressant actions similar to those of the whole volatile oil.  However, 
El Tahir et al [61] found that its mechanism of action was not similar to the central mechanism of 
the volatile oil since its effects were completely abolished by 5-HT and ACh receptor blockers. 
TQ also protected mice against doxorubicin-induced cardiotoxicity [82].
2.9.1.2 Effects on the Respiratory System
Intravenous administration of TQ into guinea-pigs in the dose range 1.6-6.4 mg/kg 
induced bronchoconstriction as evidenced by the dose-dependent and significant increases in the 
intra-tracheal pressure and potentiation of histamine-induced bronchoconstriction.  The effects 
were completely blocked by histamine H1 receptor blocker e.g. Mepyramine maleate [65].
2.9.1.3 Effects on the Liver
Treatment of dogs with TQ in doses of 1 mg/kg (i.v.) stimulated the production of bile 
salts and enhanced bile flow [83]. Studies in vitro, using isolated rat hepatocytes, revealed that 
pretreatment of the cells with TQ protected the cells from the hepatotoxicity of t-butyl 
hydroperoxide [84]. Furthermore, TQ also protected mice against CCl4-induced hepatotoxicity 
seemingly via an anti-oxidant mechanism [85, 86].
2.9.1.4 Pharmacological Actions on the Kidney
Intramuscular administration of TQ into rats in doses of 4 mg/kg/day for four days
stimulated the excretion of uric acid in urine [83]. Furthermore, oral administration of TQ to both 
rats and mice in doses of 4-5 mg/kg for several days protected the animals against cisplatin-
induced nephrotoxicity [87].
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2.9.1.5 Effect on Chemically-induced Convulsions 
Intraperitoneal administration of 40-80 mg/kg TQ in 60 minutes in mice or its 
intracebroventricular injection at doses of 200 and 400μM into rats protected significantly 
against pentylene tetrazole-induced tonic-clonic seizures and protected mice against maximal 
electroshock-induced seizures [88].  The protective effect seemed to involve an opioid receptor-
mediated activation of GABAA receptors. 
2.9.1.6 Effect on Experimental Pain 
Although, Abdel-Fattah et al [89] found that both TQ and N. sativa volatile oil induced 
anti-nociceptive action in the formalin-induced nociception in mice via activation of kappa 
opioid receptors (OP2) yet Ghannadi et al [90] reported that N. sativa volatile oil polyphenol 
(which include TQ), exhibited an antinociceptive effect in both rats and mice that did not 
involve opioid receptors.  The compounds failed to show an anti-nociceptive effect in the tail 
flick test in mice. 
2.9.1.7 Effect on Experimental Inflammations 
Intraperitoneal administration of TQ into rats in doses of 0.5-5 mg/kg produced 
significant suppression of carrageenan-induced paw edema [71]. A similar anti-inflammatory 
activity was seen following the experimental intraperitoneal injection of the volatile oil 
polyphenols against carrageenan-induced paw oedema but not croton oil-induced ear oedema in 
mice [90].  The reported analgesic effect of TQ may be due to its ability to inhibit the 
prostaglandin cyclo-oxygenase enzyme (COX) [14] and the reported anti-inflammatory effect 
may be due to the inhibitory effect of TQ on both lipoxygenase and COX enzymes [14].  An 
inhibitory effect of TQ in lipid peroxides may also be involved [14].
2.9.1.8 Effect on Tumors 
In 1998, Worthea and Ghosh [91] reported the general anti-tumor effect of thymoquinone. 
In 2005, Rooney and Ryan [92] extended these results and found that although TQ exerted 
cytotoxicity against lungs, larynx, colon and pancreas carcinomas yet it was more potent against 
the larynx ones.   In a later investigation, the authors delineated the TQ-induced cytotoxicity 
being due to the depletion of cellular glutathione and the activation of caspase-3 enzyme [93] .
2.9.1.9 Effect on Microorganisms
Studies in the 1940s and 1950s, before the discovery of TQ in N. sativa volatile oil,
appeared for the antibacterial effect of TQ against Staphylococcus aureus [94, 95] and 
Mycobacterium tuberculosis [96] and against some fungi such as Trichophyton rubrum and 
Trichophyton mentagrophytes [97-99].  In a recent publication, Kahsai [100] re-investigated the 
effect of TQ in various bacteria, confirmed its antibacterial action and reported a minimal 
inhibitory concentration of (3.6 μg/ml) against Staphylococcus aureus. The inhibitory effect was 
due to the inhibition of RNA and protein synthesis.
2.9.1.10 Effect on the Stomach
Although Marozzi et al [66] reported a TQ-induced enhancement of histamine in 
induction of gastric ulcers, yet Kanter  [68] in 2005 reported that oral administration of TQ at a 
dose of 10mg/kg orally one hour before oral absolute alcohol at a dose of 4 ml/kg to rats 
protected the animals against alcohol-induced ulcers by approximately 38% via antioxidant 
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mechanisms that involved inhibition of reactive oxygen radicals and an increase in superoxide 
dismutase availability.   In this respect the effect of TQ was less than that of the whole volatile 
oil.
2.9.2 Pharmacological Action of D-Pinene
No great attention is paid to the pharmacological actions of D-pinene, the unsaturated 
bicyclic monoterpene hydrocarbon present in N. sativa volatile oil.  However, its 
pharmacological spectrum included effects on:
2.9.2.1 Cardiovascular System 
Intravenous administration of D-pinene into rats in doses of (2-16 μl/kg) decreased both 
the arterial blood pressure and the heart rate [101].  The effects seemed to be mediated centrally at 
the site of the nucleus tractus solitarius and the vasomotor center in the medulla [101].
2.9.2.2 Effect on Microorganisms 
Studies in vitro revealed the antibacterial action of D-pinene against the acne vulgaris 
bacteria namely Propionibacterium acnes and Staphylococcus epidermidis and against 
Staphylococcus aureus [102, 103].
2.9.2.3 Effect on Tumors 
Ruch and Silger[104] reported the effectiveness of D-pinene in inhibiting hepatic epithelial 
tumors in rats; however, it failed to inhibit 7,12-dimethyl [a] anthracene-induced mammary 
carcinomas in rats [105].
2.9.2.4 Other Actions 
D-pinene has been shown to exert an anti-inflammatory action against PGE2- and
carrageenan-induced paw oedema in rats [106] and an increase in mucocillary clearance in 
patients with chronic pulmonary obstruction [107].  Administration of D-pinene (i.p.) into mice in 
doses of 5-200 μL/kg-induced dose-dependent decrease in body temperature for at least 3 hours 
by involving both serotoninergic and opioid mechanisms [67].
2.9.3 Pharmacological Actions of p-cymene
Here again p-cymene (or p-cymol) did not attract many pharmacologists as revealed by 
the paucity of data concerning its actions in various body systems. However, in 2003 El Tahir et
al., [101] reported that administration of   p-cymene in doses of 2-32 μl/kg (i.v.) into rats induced 
dose-dependent decreases in the arterial blood pressure and the heart rate, the effect was potent 
as that of N. sativa volatile oil.  The effects seemed to be mediated centrally at the level of the 
nucleus tracts solitarius and the vasomotor center [101].  Unlike D-pinene it did not affect body 
temperature in mice [67].   Its other actions included local anaesthetic effect [108] and a mild 
antibacterial action [109].
2.10 Pharmacological Actions of the De-thymoquinonated N. sativa volatile oil 
Amazed by the potent cardiovascular depressant actions and disturbed by the potent 
bronchoconstrictor action of the volatile oil that is due to thymoquinone, El Tahir et al [101]
managed to remove thymoquinone of the whole volatile oil of N. sativa and re-examined the
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cardiovascular effects of the dethymoquinonated oil.  The results revealed that intravenous 
administration of this oil into rats in doses of (2-16 μl/kg) produced dose-dependent decreases in 
both the arterial blood pressure and heart rate to an extent twice that of the whole volatile oil 
especially with regard to the induced bradycardia.  At a dose of 16 μl/kg (i.v.) the induced 
decreases in the arterial blood pressure were 18.6 ± 4.6 and 33.5 ± 8.3 mmHg and the decreases 
in the heart rate were 27.6 ± 5.9 and 53.6 ± 3%, following administration of the whole volatile 
oil and the de-thymoquinnated oil, respectively [61, 101]. These experiments also revealed the 
central mechanism of action of the dethymoquinnated volatile oil.  The de-thymoquinnated oil 
retained its tachypnic effect and lost its bronchoconstricting action (unpublished observations). 
Thus, these experiments paved the way for the use of N. sativa volatile oil without any fear from 
thymoquinone-induced bronchoconstriction [65] or its potential ulcerogenic action, if any [64].
2.11 Pharmacological Actions of the Total Oil of Nigella sativa
The term total oil of N. sativa embraces the two purified oils present in the expressed or 
solvent-extracted oil, namely the fixed oil (>30% of the seeds’ weight) and the volatile oil (0.5% 
of the seeds’ weight). However, it should be noted that some investigators don’t specify exactly 
the type of N. sativa oil used whether it is the total, fixed or volatile oil.  This review did not 
consider any study in which the exact type of the oil used was not specified.  With the above 
definition of the total oil, literature survey revealed only a few studies. These included the ability 
of the total oil to induce:
1. Suppression of pain in rats and mice at a dose level of 1 ml/kg orally [111].
2. Inhibition of thromboxane A2 and LTB4 in rat peritoneal leukocytes stimulated by 
the calcium ionophore A23187 [12].
3. Modulation of endothelial cells fibrinolytic potential by increasing the release of 
both tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-
type 1 (PAI-1) in the endothelial cells of the human umbilical vein and the human 
uterine artery [111].  It modulates the balance between fibrinolysis and thrombus 
formation.
4. Inhibition of ADP- and arachidonic acid-induced platelets aggregation by 36-38% 
whereas the methanolic extract of the same total oil inhibited ADP- and arachidonic 
acid-induced aggregation by 51 and 93%, respectively.  The anti-platelet effect was 
found to be due to presence of the compound 2-(2-methoxypropyl)-5-methyl-1, 4-
henzene diol, thymol and carvacrol [112].  The methanolic fraction also inhibited 
blood coagulation without showing any fibrinolytic activity [112].
2.12 Pharmacological Actions of the Fixed Oil 
Only limited pharmacological experiments were performed using the pure fixed oil of N.
sativa that is devoid of any volatile fraction. Two of these studies showed (a) the ability of fixed
oil to prolong the prothrombin time in rats leading to transient anticoagulant activity [113] and (b) 
El Tahir et al [114] showed that short-term treatment of normal and streptozotocin-diabetic rats
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with the fixed oil in doses of 1 and 2 ml/kg per day revealed the ability of the oil.
1. To induce desensitization of D1-adrenoceptors in the blood vessels.
2. Sensitization of E2-adrenoceptors in the blood vessels. 
3. Stimulation of conversion of arachidonic acid to vasodilatory PGE2 and 
PGI2 in normal animals.
4. Suppression of ADP-induced platelets aggregation in the normal and 
diabetic animals.
5.       Decrease in the uterine sensitivity to the oxytocic actions of both 
      oxytocin and PGE2 [66, 114].
2.13 Pharmacological Actions of D-Hederin
Treatment of four types of human carcinomas namely lung, larynx, colon and pancreas 
with D-hederin in vitro resulted in reduction of cytotoxicity, necrosis and apoptosis [92, 93].  At 
doses of 5-10 mg/kg orally to mice, for 8 or 15 days it produced significant inhibition of murine 
P388 leukemia and Lewis lung carcinoma cells [22]. Its protective action seemed to be due to 
depletion of intracellular glutathione and production of reactive oxygen species together with 
activation of caspase-3 [115].
Treatment of Hep C12 cells line with D-hederin in doses of (1.5-3 μg/ml) protected the 
cells against H2O2-induced DNA damage via scavenging free radicals and enhancing catalase 
activity [116].
Studies in mice revealed that administration of D-hederin decreased the hepatic content 
of Cytochrome P450 and the activities of the subtypes CYP 1A1, 1A2 and 2E1.  The treatment 
decreased the levels of mRNA except that of CYP 2E1 [117].  Treatment of mice with doses of  30 
μmol/kg/day S.C for 3 days protected mice from paracetamol-, bromobenzene-, CCl4-,
furosemide- and thioacetamide-induced hepatotoxicity. The protective activity seemed to be due 
to inhibition of various types of CY P450 subtypes such as CYP 1A, CYP 2A and CYP 3A [118].
Exposure of Leishmania medicana in the promastigote and amastigote stages to low 
concentrations of D-hederin potentiated the leishmanicidal action of pentamidine [119].  However, 
D-hederin was highly toxic to human’s monocytes cells [119].
2.14 Pharmacological Actions of Nigellone 
The name Nigellone was coined by Drs. Mahfouz and El-Dakhakhny in 1960 to label the 
resinous compound they isolated from the volatile oil of N. sativa. They assigned it the chemical 
formula C18H22O4. They believed that it was the active component of the volatile oil [13; 120].
However, in 1963, El Dakhakhny re-examined the extraction process of the volatile oil and 
managed to isolate a bright yellow crystalline compound with the chemical formula C10H12O2
which was characterized as thymoquinone [15]. It was then realized that nigellone was actually a 
dimer of thymoquinone previously known as dithymoquinone synthesized in 1944[121].
Thymoquinone can be converted to dithymoquinone via exposure to air to facilitate 
dimerization.
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Nigellone exerted some pharmacological actions that included protection of guinea-pigs 
against histamine-induced bronchoconstriction [83] and suppression of bronchial asthma in 
children [120, 121].  It should be pointed out that it is this report that gave the impression that the 
volatile oil of the black seed is effective in asthma!  Furthermore, it inhibited histamine release 
from egg-albumin sensitized non peritoneal mast cells [123].  It was devoid of any hypotensive 
activity [83].
2.15 Pharmacological Actions of Melanin 
Melanin is recently isolated and purified from the outer coats of the seeds of Nigella
sativa and some of its pharmacological actions were revealed.  El-Obeid et al [124] reported its 
ability to activate To11 like receptors type 4 to stimulate the release of IL-8 from PBMCs and 
other cell lines.  While, ELTahir et al   showed its ability to protect against alcohol- aspirin-
indomethacin and stress- induced ulcers in presence or absence of commensal gastric bacteria
(unpublished data). 
Concluding Remarks
The above comprehensive review almost covered what is actually known to date about 
the black seed and its constituents. It is clear that most of the potent and fruitful activity resides 
in its volatile oil and a protein component. However, the volatile oil suffers the drawback of the 
bronhoconstricting effect of thymoquinone. However, the latter can be easily removed from the 
oil to obtain dethymoquinoneated oil that has already been shown to possess the major 
characteristics of the whole oil. At this moment we have a lot of experimental data that, I hope, 
may stimulate the beginning of the era of pilot clinical studies to evaluate the clinical potential 
of the volatile oil, some of the protein fractions and the dethymoquinoneated volatile oil. It is 
hoped that this plea will have a rapid response.
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